Now Open: COVID-19 Clinical Trial Search and Trends Platform

Inato has built an open access platform that gathers all available information on COVID-19 clinical trials worldwide.The platform is available for use, free of charge, to all hospitals and PIs globally in order to:
  1. search and access the most up to date information on global COVID-19 trials
  2. digest the emerging trends in COVID-19 clinical research

Democratizing clinical research

Inato is a platform for clinical trials that unlocks research site potential around the world. Biopharmaceutical companies and CROs work with us to bring the best sites to any given study and ensure that our partners deliver trials successfully.

We designed our platform with doctors and for doctors

We make sure they have access to the right trials for their patients – so they can run clinical trials with a dramatically reduced administrative burden. To date, more than 2000 sites and 3500 doctors have used our platform in 75 countries. Headquartered in Paris with offices in New York, we are backed by Obvious Ventures, Cathay Innovation, Serena, and Fly Ventures.

2000+

sites

3500+

doctors

75

countries

The team

We have a growing team of physicians and pharmaceutical experts, data and software engineers, and professional services managers – all bringing their unique perspectives to solve challenging problems in clinical research.

Together, we are creating the foundation for a modern approach to clinical research, one that will engage a broader pool of sites and patients than ever before.

Our investors